SCHEMBL7992335

SCHEMBL7992335

CCc1nc2ncn(Cc3cc(C(C)(C)C)c(OCc4ccccc4)c(C(C)(C)C)c3)c2c(=O)[nH]1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
ALDH1A1 P00352 4/20 0.44
KMT2A Q03164 4/20 0.43
GAA P10253 1/20 0.38
BRD4 O60885 2/20 0.37
MEN1 O00255 2/20 0.35
HTT P42858 2/20 0.35
HCAR2 Q8TDS4 1/20 0.35
XBP1 P17861 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TNKS2 Q9H2K2 1/20 0.34
MAPK14 Q16539 1/20 0.34
ADORA3 P0DMS8 2/20 0.34
PARN O95453 1/20 0.34
CNOT7 Q9UIV1 1/20 0.34
PNP P00491 1/20 0.34
NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7987442 0.88 HPGD (0.46) HPGDSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL7992340 0.85 CNOT7 (0.40) HPGDSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL7975251 0.83 SMN1; SMN2 (0.60) HPGDSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL7987778 0.82 ALDH1A1 (0.51) HPGDSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL7985527 0.82 HPGD (0.41) HPGDSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL7992337 0.79 GAA (0.35) HPGDSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL7984464 0.77 ABCC8 (0.50) HPGDSMN1; SMN2ALDH1A1KMT2ABRD4
SCHEMBL7973932 0.77 SMN1; SMN2 (0.53) HPGDSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL7985469 0.77 SMN1; SMN2 (0.57) HPGDSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL7984374 0.76 HPGD (0.43) HPGDSMN1; SMN2ALDH1A1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed